Rodney Roberts, MD
Family Medicine · Decatur, TNNPI 1306847785
Payments from drug & device makers
Across 254 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$375
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$363
- Takeda Pharmaceuticals U.S.A., Inc.$322
- Lilly USA, LLC$217
- Esperion Therapeutics, Inc.$204
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,300100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 68 | $1,158 |
| AbbVie | 20 | $375 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $363 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $322 |
| Lilly USA, LLC | 15 | $217 |
| Esperion Therapeutics, Inc. | 13 | $204 |
| Amgen | 10 | $156 |
| Johnson & Johnson | 8 | $132 |
| AstraZeneca | 9 | $130 |
| Pfizer | 8 | $128 |
| Phathom Pharmaceuticals, Inc. | 7 | $112 |
| Genentech USA, Inc. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Bayer | 4 | $69 |
| Eisai Inc. | 4 | $68 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Novartis | 4 | $66 |
| Abbott | 3 | $65 |
| Philips North America LLC | 3 | $55 |
| Boehringer Ingelheim | 4 | $50 |
| Gilead | 2 | $42 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $38 |
| Merck | 3 | $35 |
| Boston Scientific | 1 | $31 |
| Lundbeck LLC | 1 | $30 |
| GSK | 1 | $22 |
| Nuwellis, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Aytu Biopharma, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Exact Sciences | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$4,300 in reported general payments places this provider in the 80th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $68,398 |
| JardianceEmpagliflozin | 25 | $39,129 |
| OzempicSemaglutide | 30 | $28,878 |
| JanuviaSitagliptin Phosphate | 15 | $14,790 |
| XareltoRivaroxaban | 12 | $12,812 |
| Rivastigmine | 34 | $9,733 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 60 | $9,075 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $3,835 |
| Bumetanide | 37 | $3,090 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $2,632 |
| Levothyroxine Sodium | 337 | $2,400 |
| Omeprazole | 206 | $2,325 |
| Atorvastatin Calcium | 297 | $2,044 |
| Potassium Chloride | 82 | $1,889 |
| Ezetimibe | 127 | $1,876 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $128 | $68,39871 claims |
| Boehringer IngelheimJardiance | $50 | $39,12925 claims |
| Novo NordiskOzempic | $1,158 | $28,87830 claims |
| MerckJanuvia | $35 | $14,79015 claims |
| Johnson & JohnsonXarelto | $132 | $12,81212 claims |
| AbbVieSynthroid | $375 | $1,76922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Decatur
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
- Marcus LeeTullahoma$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.